Home Cart Sign in  
Chemical Structure| 1393465-84-3 Chemical Structure| 1393465-84-3

Structure of PLX7904
CAS No.: 1393465-84-3

Chemical Structure| 1393465-84-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PLX7904 is a Raf inhibitor, inhibits the growth of two melanoma cell lines (A375 and COLO829) and human colorectal cancer cell line COLO205 that expressed BRAFV600E with IC50 values of 0.17 μM, 0.53 μM, and 0.16 μM, respectively.

Synonyms: PB04

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PLX7904

CAS No. :1393465-84-3
Formula : C24H22F2N6O3S
M.W : 512.53
SMILES Code : O=S(NC1=CC=C(F)C(C(C2=CNC3=NC=C(C4=CN=C(C5CC5)N=C4)C=C32)=O)=C1F)(N(CC)C)=O
Synonyms :
PB04
MDL No. :MFCD29472265

Safety of PLX7904

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of PLX7904

MAPK

Isoform Comparison

Biological Activity

Target
  • Raf

In Vitro:

Cell Line
Concentration Treated Time Description References
RPE-1 FUCCI cells 1 µM Inhibition of BRAFV600E-induced tetraploid cell formation PMC9287415
1205LuTR reporter cells 1 μM 24 h PLX7904 inhibited phosphorylation of ERK1/2 PMC3988223
PRT #3 and PRT #4 cells 1 μM 24 h PLX7904 inhibited phosphorylation of ERK1/2 PMC3988223
LM-COL-1 1 μM 6 h To verify whether PLX8394 could avoid paradoxical activation of the MAPK signaling pathway in LM-COL-1 cells, results showed minimal effect of PLX8394 on pMEK and pERK. PMC5490236
ALA 1 μM 6 h To verify whether PLX8394 could avoid paradoxical activation of the MAPK signaling pathway in ALA cells, results showed minimal effect of PLX8394 on pMEK and pERK. PMC5490236
LS513 1 μM 6 h To verify whether PLX8394 could avoid paradoxical activation of the MAPK signaling pathway in LS513 cells, results showed minimal effect of PLX8394 on pMEK and pERK. PMC5490236
HCT 116 1 μM 6 h To verify whether PLX8394 could avoid paradoxical activation of the MAPK signaling pathway in HCT 116 cells, results showed minimal effect of PLX8394 on pMEK and pERK. PMC5490236
WM793 cells 0.05, 0.1, 1, 5 μM 24 h To evaluate the inhibitory effect of PLX7904 on ERK1/2 phosphorylation PMC3695051
HaCaT HRAS G12V cells 0.05, 0.1, 1, 5 μM 1 h To evaluate the inhibitory effect of PLX7904 on ERK1/2 phosphorylation PMC3695051
PAM 212 cells 0.05, 0.1, 1, 5 μM 1 h To evaluate the inhibitory effect of PLX7904 on ERK1/2 phosphorylation PMC3695051

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
nude mice 1205LuTR reporter cell xenograft model oral 417 ppm 6 weeks Generate PLX4720-resistant cell lines PMC3988223

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.95mL

0.39mL

0.20mL

9.76mL

1.95mL

0.98mL

19.51mL

3.90mL

1.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories